134 related articles for article (PubMed ID: 22972808)
21. The value of mammography in different ethnic groups in Israel--analysis of mortality reduction and costs using CAN*TROL.
Rennert G
Cancer Detect Prev; 1991; 15(6):477-81. PubMed ID: 1723656
[TBL] [Abstract][Full Text] [Related]
22. Estimates of overdiagnosis of invasive breast cancer associated with screening mammography.
Morrell S; Barratt A; Irwig L; Howard K; Biesheuvel C; Armstrong B
Cancer Causes Control; 2010 Feb; 21(2):275-82. PubMed ID: 19894130
[TBL] [Abstract][Full Text] [Related]
23. Minor influence of self-selection bias on the effectiveness of breast cancer screening in case-control studies in the Netherlands.
Paap E; Verbeek A; Puliti D; Broeders M; Paci E
J Med Screen; 2011; 18(3):142-6. PubMed ID: 22045823
[TBL] [Abstract][Full Text] [Related]
24. Narrowing the equity gap: the impact of organized versus opportunistic cancer screening in Catalonia (Spain).
Espinas JA; Aliste L; Fernandez E; Argimon JM; Tresserras R; Borras JM
J Med Screen; 2011; 18(2):87-90. PubMed ID: 21852701
[TBL] [Abstract][Full Text] [Related]
25. [Population-based breast cancer screening is not worthwhile. Screening has little effect on mortality].
Bonneux LG; Autier P
Ned Tijdschr Geneeskd; 2011; 155(35):A3774. PubMed ID: 21902850
[TBL] [Abstract][Full Text] [Related]
26. False-positive results in mammographic screening for breast cancer in Europe: a literature review and survey of service screening programmes.
Hofvind S; Ponti A; Patnick J; Ascunce N; Njor S; Broeders M; Giordano L; Frigerio A; Törnberg S; ; Van Hal G; Martens P; Májek O; Danes J; von Euler-Chelpin M; Aasmaa A; Anttila A; Becker N; Péntek Z; Budai A; Mádai S; Fitzpatrick P; Mooney T; Zappa M; Ventura L; Scharpantgen A; Hofvind S; Seroczynski P; Morais A; Rodrigues V; Bento MJ; Gomes de Carvalho J; Natal C; Prieto M; Sánchez-Contador Escudero C; Zubizarreta Alberti R; Fernández Llanes SB; Ascunce N; Ederra Sanza M; Sarriugarte Irigoien G; Salas Trejo D; Ibáñez Cabanell J; Wiege M; Ohlsson G; Törnberg S; Korzeniewska M; de Wolf C; Fracheboud J; Patnick J; Lancucki L; Ducarroz S; Suonio E
J Med Screen; 2012; 19 Suppl 1():57-66. PubMed ID: 22972811
[TBL] [Abstract][Full Text] [Related]
27. Screening mammography--early detection or over-diagnosis? Contribution from Australian data.
Bell RJ
Climacteric; 2014 Dec; 17 Suppl 2():66-72. PubMed ID: 25224048
[TBL] [Abstract][Full Text] [Related]
28. European breast cancer service screening outcomes: a first balance sheet of the benefits and harms.
Paci E; Broeders M; Hofvind S; Puliti D; Duffy SW;
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1159-63. PubMed ID: 24991022
[TBL] [Abstract][Full Text] [Related]
29. The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges.
Broeders M; Paci E
Womens Health (Lond); 2015 Nov; 11(6):883-90. PubMed ID: 26619214
[TBL] [Abstract][Full Text] [Related]
30. The effect of population-based mammography screening in Dutch municipalities on breast cancer mortality: 20 years of follow-up.
Sankatsing VDV; van Ravesteyn NT; Heijnsdijk EAM; Looman CWN; van Luijt PA; Fracheboud J; den Heeten GJ; Broeders MJM; de Koning HJ
Int J Cancer; 2017 Aug; 141(4):671-677. PubMed ID: 28457023
[TBL] [Abstract][Full Text] [Related]
31. Breast cancer mortality trends in England and the assessment of the effectiveness of mammography screening: population-based study.
Mukhtar TK; Yeates DR; Goldacre MJ
J R Soc Med; 2013 Jun; 106(6):234-42. PubMed ID: 23761583
[TBL] [Abstract][Full Text] [Related]
32. Impact of mammography screening programmes on breast cancer mortality in Switzerland, a country with different regional screening policies.
Herrmann C; Vounatsou P; Thürlimann B; Probst-Hensch N; Rothermundt C; Ess S
BMJ Open; 2018 Mar; 8(3):e017806. PubMed ID: 29540406
[TBL] [Abstract][Full Text] [Related]
33. Assessment of Breast Cancer Mortality Trends Associated With Mammographic Screening and Adjuvant Therapy From 1986 to 2013 in the State of Victoria, Australia.
Burton R; Stevenson C
JAMA Netw Open; 2020 Jun; 3(6):e208249. PubMed ID: 32573707
[TBL] [Abstract][Full Text] [Related]
34. Pitfalls in using case-control studies for the evaluation of the effectiveness of breast screening programmes.
Autier P; Boniol M
Eur J Cancer Prev; 2013 Sep; 22(5):391-7. PubMed ID: 23263568
[TBL] [Abstract][Full Text] [Related]
35. How effective are breast cancer screening programmes by mammography? Review of the current evidence.
Schopper D; de Wolf C
Eur J Cancer; 2009 Jul; 45(11):1916-23. PubMed ID: 19398327
[TBL] [Abstract][Full Text] [Related]
36. Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging.
Monticciolo DL; Newell MS; Hendrick RE; Helvie MA; Moy L; Monsees B; Kopans DB; Eby PR; Sickles EA
J Am Coll Radiol; 2017 Sep; 14(9):1137-1143. PubMed ID: 28648873
[TBL] [Abstract][Full Text] [Related]
37. Development of breast cancer mortality considering the implementation of mammography screening programs - a comparison of western European countries.
Iwamoto Y; Kaucher S; Lorenz E; Bärnighausen T; Winkler V
BMC Public Health; 2019 Jun; 19(1):823. PubMed ID: 31242882
[TBL] [Abstract][Full Text] [Related]
38. Breast cancer screening: are we seeing the benefit?
Puliti D; Zappa M
BMC Med; 2012 Sep; 10():106. PubMed ID: 22995098
[TBL] [Abstract][Full Text] [Related]
39. Breast Cancer Mortality After Implementation of Organized Population-Based Breast Cancer Screening in Norway.
Sebuødegård S; Botteri E; Hofvind S
J Natl Cancer Inst; 2020 Aug; 112(8):839-846. PubMed ID: 31848605
[TBL] [Abstract][Full Text] [Related]
40. Estimating the benefits of mammography screening: the impact of study design.
Olsen AH; Njor SH; Lynge E
Epidemiology; 2007 Jul; 18(4):487-92. PubMed ID: 17486020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
